Shandong Weigao Group Medical Polymer. 

$0.4200
24
-$0.01-2.57%Tuesday 21:00

Statistics

Day High
0.4311
Day Low
0.4311
52W High
0.73
52W Low
0.4
Volume
1,731
Avg. Volume
431
Mkt Cap
1.92B
P/E Ratio
8.6
Dividend Yield
5.11%
Dividend
0.02

Upcoming

Dividends

5.11%Dividend Yield
Nov 2026
$0.01
Jul 2026
$0.01
Nov 2025
$0.01
Jul 2025
$0.02
Nov 2024
$0.01
10Y Growth
6.8%
5Y Growth
2.59%
3Y Growth
-1.41%
1Y Growth
-25.52%

Earnings

Aug 25Expected
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
0
0.09
0.19
0.28
Expected EPS
0.196114465272
Actual EPS
0.196114465272

Financials

12%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
1.89BRevenue
227.07MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SHWGF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap123.49B
Medtronic is a global leader in medical technology, services, and solutions, competing directly in the medical devices sector with Shandong Weigao Medical Polymer.
Boston Scientific
BSX
Mkt Cap60.84B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, competing in areas such as cardiovascular and endoscopy products.
Stryker
SYK
Mkt Cap111.95B
Stryker Corporation specializes in reconstructive, medical and surgical, and neurotechnology and spine products, directly competing with Shandong Weigao's range of medical devices.
Zimmer Biomet
ZBH
Mkt Cap18.03B
Zimmer Biomet Holdings, Inc. is a competitor in the musculoskeletal healthcare sector, offering products that compete with Shandong Weigao's orthopedic and surgical devices.
Abbott Laboratories
ABT
Mkt Cap183.77B
Abbott Laboratories operates in various segments, including medical devices, competing with Shandong Weigao in areas like vascular and diabetes care.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson operates in the healthcare field, with its medical devices segment offering products that compete across several of Shandong Weigao's product lines.
Baxter International
BAX
Mkt Cap11.9B
Baxter International Inc. provides a broad portfolio of essential healthcare products, including advanced surgical equipment and devices, competing in the medical supplies and devices sector.
Becton Dickinson
BDX
Mkt Cap53.9B
Becton, Dickinson and Company is a global medical technology company that manufactures and sells medical devices, instrument systems, and reagents, competing in the medical supplies field.
Edwards Lifesciences
EW
Mkt Cap53.03B
Edwards Lifesciences Corporation specializes in heart valves and hemodynamic monitoring, competing with Shandong Weigao in the cardiovascular device market.
Intuitive Surgical
ISRG
Mkt Cap152.62B
Intuitive Surgical, Inc. develops, manufactures, and markets robotic products for minimally invasive surgery, competing in the innovative surgical devices and equipment sector.

About

Shandong Weigao Group Medical Polymer Company Limited, founded in 2000 and situated in Weihai, People's Republic of China, specializes in the research, development, production, and distribution of disposable medical devices across mainland China. The company structures its extensive operations into several core divisions, including Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and other specialized segments. Its comprehensive product range covers a vast array of essential healthcare items. This includes devices for both vascular and non-vascular access, such as infusion sets, syringes, and specialized puncture needles, alongside various clinical collection kits. Shandong Weigao also provides solutions for wound care, offering sutures, healing dressings, cleaning products, and support devices for non-vascular catheters. In the realm of blood management, it supplies equipment for collection, storage, separation, and sterilization. The company is also a manufacturer of prefilled and pre-flush syringes, as well as instruments for blood collection and glucose monitoring. Its portfolio further extends to anesthesia consumables (general, local, and auxiliary), intensive care unit (ICU) equipment, and tools for both open and minimally invasive surgical procedures. Beyond disposables, the firm is a key producer of orthopedic devices, instruments for tumor and blood vessel interventions, and advanced medical components such as implantation materials and artificial organs. It also ventures into industrial manufacturing, producing medical-grade PVC granules, various plastic packaging materials, carton boxes, automated industrial equipment and parts, molds, and hemodialysis machines, encompassing Type I, Type II, and Type III medical devices. In addition to its manufacturing activities, Shandong Weigao offers a range of supporting services. These include finance leasing and factoring, wholesale distribution of Type I, surgical, and other disposable medical products. The company also provides asset management, enterprise consulting, management advisory, and comprehensive logistics and storage solutions, while actively exporting its products to international markets. Operating under recognized brands like Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing, the company serves a diverse clientele that includes hospitals, blood banks, various other medical facilities, and a broad network of distributors.
Show More
CEO
Rinan Cong
Employees
13310
Country
China
ISIN
CNE100000171
WKN
000A0M4WA

Listings

0 Comments

Share your thoughts

FAQs

What is Shandong Weigao Group Medical Polymer. stock price today?▼
The current price of SHWGF is $0.42 USD — it has decreased by -2.57% in the past 24 hours. Watch Shandong Weigao Group Medical Polymer. stock price performance more closely on the chart.
What is Shandong Weigao Group Medical Polymer. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Shandong Weigao Group Medical Polymer. stocks are traded under the ticker SHWGF.
Is Shandong Weigao Group Medical Polymer. stock price growing?▼
SHWGF stock has fallen by -2.57% compared to the previous week, the month change is a +0% rise, over the last year Shandong Weigao Group Medical Polymer. has showed a -39.12% decrease.
What is Shandong Weigao Group Medical Polymer. market cap?▼
Today Shandong Weigao Group Medical Polymer. has the market capitalization of 1.92B
When is the next Shandong Weigao Group Medical Polymer. earnings date?▼
Shandong Weigao Group Medical Polymer. is going to release the next earnings report on March 30, 2027.
What were Shandong Weigao Group Medical Polymer. earnings last quarter?▼
SHWGF earnings for the last quarter are 0.03 USD per share, whereas the estimation was 0.03 USD resulting in a +0% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Shandong Weigao Group Medical Polymer. revenue for the last year?▼
Shandong Weigao Group Medical Polymer. revenue for the last year amounts to 1.89B USD.
What is Shandong Weigao Group Medical Polymer. net income for the last year?▼
SHWGF net income for the last year is 227.07M USD.
Does Shandong Weigao Group Medical Polymer. pay dividends?▼
Yes, SHWGF dividends are paid semi-annual. The last dividend per share was 0.01 . As of today, Dividend Yield (FWD)% is 5.11%.
How many employees does Shandong Weigao Group Medical Polymer. have?▼
As of November 8, 2026, the company has 13,310 employees.
In which sector is Shandong Weigao Group Medical Polymer. located?▼
Shandong Weigao Group Medical Polymer. operates in the Health & Wellness sector.
When did Shandong Weigao Group Medical Polymer. complete a stock split?▼
The last stock split for Shandong Weigao Group Medical Polymer. was on May 4, 2011 with a ratio of 2:1.
Where is Shandong Weigao Group Medical Polymer. headquartered?▼
Shandong Weigao Group Medical Polymer. is headquartered in Weihai, China.